semaglutide mash fda approval Big news in liver health! 📣 (metabolic dysfunction-associated steatohepatitis) is part of a group of metabolic liver diseases that has become the #1 cause of liver disease in America, and now Wegovy Is Now the Second

If approved, the prescription is sent to a partner pharmacy

(Endocrine Reviews, 1991) documented that combined GHRH + GHS-R agonist administration produces GH release 2-5 fold greater than either compound alone, providing the scientific rationale for the CJC-1295 ipamorelin blend approach

Zepbound and Ozempic should not be used by people with a personal or family history of medullary thyroid carcinoma or by people with Multiple Endocrine Neoplasia syndrome type 2

Some mechanistic hypotheses suggest that diabetic patients, due to altered gastric emptying, autonomic neuropathy, or baseline gastrointestinal dysmotility, may be more susceptible to the GI side effects associated with GLP-1 RAs